All Relations between dopaminergic and dopamine

Publication Sentence Publish Date Extraction Date Species
M Goldstein, A Lieberman, J Y Lew, T Asano, M R Rosenfeld, M H Makma. Interaction of pergolide with central dopaminergic receptors. Proceedings of the National Academy of Sciences of the United States of America. vol 77. issue 6. 1980-11-25. PMID:6932044. thus, pergolide, unlike other dopaminergic ergots, acts as an agonist on gtp-sensitive components of [3h]spi binding and stimulates dopamine receptors linked to dopamine-sensitive adenylate cyclase. 1980-11-25 2023-08-12 rat
N Faure, M J Cronin, J A Martial, R I Weine. Decreased responsiveness of GH3 cells to the dopaminergic inhibition of prolactin. Endocrinology. vol 107. issue 4. 1980-11-24. PMID:6157521. the inhibitory regulation of prl secretion by dopamine (da) or the dopaminergic agonists bromergocryptine (cb-154) and apomorphine was studied in cultured gh3 cells, an established rat anterior pituitary cell line which produces both prl and gh. 1980-11-24 2023-08-12 rat
M D Schechte. Caffeine potentiation of apomorphine discrimination. Pharmacology, biochemistry, and behavior. vol 13. issue 2. 1980-11-24. PMID:6251484. the results are consistent with the idea that caffeine, by virtue of being a phosphodiesterase inhibitor, may increase post-synaptic cyclic-amp and this, in turn, may supersensitize the dopamine receptors and result in the potentiation of the apomorphine-induced dopaminergic responses. 1980-11-24 2023-08-12 rat
A J Cross, F Owe. Characteristics of 3H-cis-flupenthixol binding to calf brain membranes. European journal of pharmacology. vol 65. issue 4. 1980-11-24. PMID:7408943. the potencies of neuroleptics, dopaminergic ergot alkaloids and dopamine (da) agonists in inhibiting 3h-fpt binding to calf striatal membranes were compared with their potencies in inhibiting 3h-spiperone (3h-spip) binding and da-stimulated adenylate cyclase (ac). 1980-11-24 2023-08-12 Not clear
A Enjalbert, S Arancibia, M Ruberg, M Priam, M T Bluet-Pajot, W H Rotsztejn, C Kordo. Stimulation of in vitro prolactin release by vasoactive intestinal peptide. Neuroendocrinology. vol 31. issue 3. 1980-11-24. PMID:7413020. the effect of vip was not blocked by alpha-flupentixol, a potent dopaminergic antagonist, at concentrations which antagonized the dopamine inhibition of prolactin secretion. 1980-11-24 2023-08-12 rat
H Y Meltze. Relevance of dopamine autoreceptors for psychiatry: preclinical and clinical studies. Schizophrenia bulletin. vol 6. issue 3. 1980-10-27. PMID:6105707. stimulation of these autoreceptors by dopamine agonists decreases dopaminergic activity. 1980-10-27 2023-08-12 Not clear
H Y Meltze. Relevance of dopamine autoreceptors for psychiatry: preclinical and clinical studies. Schizophrenia bulletin. vol 6. issue 3. 1980-10-27. PMID:6105707. preliminary clinical studies suggest that administration of low doses of conventional dopamine agonists such as apomorphine can inhibit the activity of some dopaminergic neurons and be of therapeutic use in the treatment of excited psychotic states and a variety of abnormal movement disorders. 1980-10-27 2023-08-12 Not clear
B Scatto. Effect of repeated treatment with neuroleptics on dopamine metabolism in cell bodies and terminals of dopaminergic systems in the rat brain. Advances in biochemical psychopharmacology. vol 24. 1980-10-27. PMID:6105783. effect of repeated treatment with neuroleptics on dopamine metabolism in cell bodies and terminals of dopaminergic systems in the rat brain. 1980-10-27 2023-08-12 rat
A V Christensen, I M Nielse. Dopaminergic supersensitivity: influence of dopamine agonists and drugs used for the treatment of tardive dyskinesia. Advances in biochemical psychopharmacology. vol 24. 1980-10-27. PMID:6105784. dopaminergic supersensitivity: influence of dopamine agonists and drugs used for the treatment of tardive dyskinesia. 1980-10-27 2023-08-12 Not clear
P L Hoffman, B Tabakof. Modification of dopamine receptor-mediated processes after chronic ethanol intoxication: a possible mechanism. Advances in experimental medicine and biology. vol 126. 1980-10-27. PMID:7190764. autonomic and behavioral response to dopaminergic agonists were reduced, as was the stimulation by dopamine of dopamine-sensitive adenylate cyclase from the striatal region of brain. 1980-10-27 2023-08-12 Not clear
S Lahiri, T Nishino, A Mokashi, E Mulliga. Interaction of dopamine and haloperidol with O2 and CO2 chemoreception in carotid body. Journal of applied physiology: respiratory, environmental and exercise physiology. vol 49. issue 1. 1980-10-21. PMID:6772612. effects of dopamine and of a dopaminergic blocker, haloperidol, on the responses of carotid body chemoreceptors to hypoxia and hypercapnia were investigated in 16 anesthetized cats. 1980-10-21 2023-08-12 cat
M J Bannon, E B Bunney, J R Zigun, L R Skirboll, R H Rot. Presynaptic dopamine receptors: insensitivity to kainic acid and the development of supersensitivity following chronic haloperidol. Naunyn-Schmiedeberg's archives of pharmacology. vol 312. issue 2. 1980-10-21. PMID:6772975. following the gamma-butyrolactone-induced inhibition of dopaminergic impulse flow, and after dopa decarboxylase inhibition, dopa accumulation and its reversal by dopamine agonists was measured in vivo. 1980-10-21 2023-08-12 rat
B H Westerink, D Dijkstra, M G Feenstra, A S Horn, H Rollem. Selective storage in vivo of 5,6-ADTN in dopamine-rich areas of the rat brain. European journal of pharmacology. vol 64. issue 2-3. 1980-10-21. PMID:7398758. this study investigates the mechanism of the selective storage of the dopamine agonist 2-amino-5,6-dihydroxytetrahydronaphthalene (5,6-adtn, used as the esterified prodrug) in densely innervated dopaminergic brain structures. 1980-10-21 2023-08-12 rat
R H Alper, K T Demarest, K E Moor. Dehydration selectively increases dopamine synthesis in tuberohypophyseal dopaminergic neurons. Neuroendocrinology. vol 31. issue 2. 1980-09-28. PMID:6771668. dehydration selectively increases dopamine synthesis in tuberohypophyseal dopaminergic neurons. 1980-09-28 2023-08-12 rat
T C Hagen, A J Sill, T L Garthwaite, G Halverson, H I Borkow. Prolactin and growth hormone responses in the amenorrhea-galactorrhea syndrome. Obstetrics and gynecology. vol 56. issue 2. 1980-09-28. PMID:7190256. the disordered growth hormone response to dopaminergic agents suggests a central disorder of dopamine generation. 1980-09-28 2023-08-12 Not clear
M E Quigley, S S Ye. Evidence for increased dopaminergic inhibition of secretion of thyroid-stimulating hormone in hyperprolactinemic patients with pituitary microadenoma. American journal of obstetrics and gynecology. vol 137. issue 6. 1980-09-28. PMID:7395929. this study provides evidence of an inhibitory role of hypothalamic dopamine in the regulation of secretion of tsh and suggests an increased dopaminergic inhibition of secretion of tsh in these patients with prolactin-secreting tumors. 1980-09-28 2023-08-12 Not clear
D E Case. Pharmacology of blepharospasm-oromandibular dystonia syndrome. Neurology. vol 30. issue 7 Pt 1. 1980-09-26. PMID:7190236. the effect of cholinergic agents was less than the effect of dopaminergic drugs, implying that dopamine plays a predominant role in the pathophysiology. 1980-09-26 2023-08-12 Not clear
L Annunziato, R I Weine. Characteristics of dopamine uptake and 3,4-dihydroxyphenylacetic acid (DOPAC) formation in the dopaminergic terminals of the neurointermediate lobe of the pituitary gland. Neuroendocrinology. vol 31. issue 1. 1980-09-26. PMID:7393406. characteristics of dopamine uptake and 3,4-dihydroxyphenylacetic acid (dopac) formation in the dopaminergic terminals of the neurointermediate lobe of the pituitary gland. 1980-09-26 2023-08-12 rat
L Annunziato, R I Weine. Characteristics of dopamine uptake and 3,4-dihydroxyphenylacetic acid (DOPAC) formation in the dopaminergic terminals of the neurointermediate lobe of the pituitary gland. Neuroendocrinology. vol 31. issue 1. 1980-09-26. PMID:7393406. the kinetics of dopamine (da) uptake were studied in synaptosomal preparations of the neurointermediate lobe (nil) of the pituitary gland, a region containing the terminals of the tuberoinfundibular dopaminergic neurons. 1980-09-26 2023-08-12 rat
M J Bannon, A A Grace, B S Bunney, R H Rot. Evidence for an irreversible interaction of bromocryptine with central dopamine receptors. Naunyn-Schmiedeberg's archives of pharmacology. vol 312. issue 1. 1980-09-23. PMID:6104795. the effects of the dopamine agonist bromocryptine on several measures dopaminergic function were assessed in the rat. 1980-09-23 2023-08-12 rat